ReNeuron Group Plc (RENE) Chief Executive Officer Michael Hunt said he expects researchers to report that people disabled by strokes showed progress and weren't harmed in an early-stage test of the company's stem-cell treatment.

ReNeuron Group Plc Chief Executive Officer Michael Hunt said he expects researchers to report that people disabled by strokes showed progress and weren't harmed in an early-stage test of the company's stem-cell treatment.

Overall Market Tasty PLC 76.00 5.56% Churchill Mining PLC 30.00 5.26% MEDGENICS INC. COM SHS USD0.0001 (D 300.00 4.35% Pentagon Protection PLC 20.50 3.80% ReNeuron Group PLC 2.63 3.14% PowerHouse Energy 1.00 -8.26% Karelian ...